MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies.

Dhas Y, Arshad N, Biswas N, Jones LD, Ashili S.

Open source

DOI
10.3390/biomedicines11092583
Published
2023-09-20
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines11092583,
  title = {MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies.},
  author = {Dhas Y and  Arshad N and  Biswas N and  Jones LD and  Ashili S.},
  year = {2023},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines11092583},
  url = {https://doi.org/10.3390/biomedicines11092583}
}

RIS

TY  - JOUR
TI  - MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies.
AU  - Dhas Y
AU  -  Arshad N
AU  -  Biswas N
AU  -  Jones LD
AU  -  Ashili S.
PY  - 2023
JO  - Biomedicines
DO  - 10.3390/biomedicines11092583
UR  - https://doi.org/10.3390/biomedicines11092583
ER  - 

APA

Y, D., N, A., N, B., LD, J., & S., A. (2023). MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies.. Biomedicines. https://doi.org/10.3390/biomedicines11092583

Source records